In a nutshell: Haematological immune‐related adverse events
0 citations
Abstract
Summary The use of immune checkpoint inhibitors (ICIs) have transformed oncological care. In this ‘nutshell review’, we summarize the most common haematological immune‐related adverse events (irAEs) associated with checkpoint inhibitors. We also outline management strategies and address current evidence regarding ICI rechallenge.
// Source
Authors: Rebecca Karp Leaf, Jodi V. Mones
Institutions: Harvard University, Memorial Sloan Kettering Cancer Center, Global Cancer Institute